I do just wonder whether this is all part of a push for a NASDAQ dual listing. It's been a longstanding rumour, but perhaps they feel their market cap and increased exposure puts them in a good position to do it. Acquisitions and upping their marketing spend there would help, but there's something about being listed on the NASDAQ alongside their contemporaries, eg Salesforce and Square and Intuit the like that would give them instant credibility, profile and exposure to the US market. With the size of the company now and ACMR approaching $1b, it just feels like the time might be right soon to make the move?
- Forums
- ASX - By Stock
- XRO
- Ann: Xero prices zero coupon US$700m convertible notes
Ann: Xero prices zero coupon US$700m convertible notes, page-11
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add XRO (ASX) to my watchlist
(20min delay)
|
|||||
Last
$161.14 |
Change
1.520(0.95%) |
Mkt cap ! $24.61B |
Open | High | Low | Value | Volume |
$160.55 | $161.66 | $158.99 | $74.60M | 464.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1184 | $160.71 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$161.14 | 879 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1184 | 160.710 |
1 | 141 | 160.610 |
1 | 1184 | 160.580 |
1 | 1184 | 160.450 |
1 | 2483 | 160.400 |
Price($) | Vol. | No. |
---|---|---|
161.140 | 879 | 1 |
161.310 | 1184 | 1 |
161.390 | 141 | 1 |
161.400 | 23 | 1 |
161.440 | 1184 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
XRO (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online